Alkaline and acid phosphatase inhibitors in treatment of neurological disorders
US5567724A · kind A · utility
105Cited by
23References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 1, 1994 |
| Grant date | Oct 22, 1996 |
| Priority date | — |
| Expiry date | Jun 1, 2014 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a method of inhibiting .beta.-amyloid toxicity in brain cells. The method includes administering to the cells an amount of an alkaline phosphatase inhibitor which is pharmacologically effective to reduce degeneration in the cells. Methods of treatment of peripheral neuropathy are also provided using acid or alkaline phosphatase inhibitors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.